Curaleaf Holdings, Inc. filed a current report on November 10, 2026, disclosing that it has received all required competition law clearances for its proposed acquisition of Aurora Cannabis.

Key Highlights

  • All competition clearances obtained: Curaleaf confirmed it has received every required competition law clearance for the proposed Aurora Cannabis acquisition.
  • Event date: The statement was issued by Curaleaf on November 10, 2026.
  • Signed by Chief Legal Officer: The report was signed by Peter Clateman, Curaleaf's Chief Legal Officer.
  • Written communications filing: The report was filed pursuant to Rule 425 under the Securities Act, covering written communications related to the transaction.
  • No securities registered under Section 12(b): According to the filing, Curaleaf has no securities registered pursuant to Section 12(b) of the Act.

Curaleaf Confirms Regulatory Milestone in Aurora Cannabis Deal

Curaleaf Holdings, Inc., a cannabis company incorporated in British Columbia, Canada, with principal executive offices at 250 Harbor Drive, Third Floor, Stamford, Connecticut 06902, disclosed on November 10, 2026 that it has received all required competition law clearances for its proposed acquisition of Aurora Cannabis. The confirmation was issued through a press release, referenced in the filing as Exhibit 99.1, dated November 10, 2026.

The filing was made under Item 8.01 (Other Events) and was simultaneously filed pursuant to Rule 425 under the Securities Act of 1934, which applies to written communications made in connection with business combination transactions. According to the filing, the information included in the current report, including the attached press release, "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934." Curaleaf's shares are traded on the OTC market under the ticker CURLF, as reflected in the filing identifier.

The report was authorized and signed on behalf of Curaleaf by Peter Clateman, identified in the filing as Chief Legal Officer. No financial statements were included as part of this disclosure. The filing does not specify additional conditions remaining before the transaction can close, nor does it provide a projected closing date, based on the content available in the source document.

What Was Disclosed

Curaleaf Holdings reported in a November 10, 2026 current report that all required competition law clearances have been received for the company's proposed acquisition of Aurora Cannabis, with the disclosure signed by Chief Legal Officer Peter Clateman.